Introduction {#s02}
============

The release of Ca^2+^ ions from intracellular membrane-bound stores is a key step in a wide variety of biological functions. The release of Ca^2+^ is predominantly mediated by two related Ca^2+^ release channel families: the ryanodine receptors (RyRs; [@bib145]; [@bib62]; [@bib90]; [@bib33]) and inositol 1,4,5-trisphosphate receptors ([@bib167]; [@bib201]; [@bib9]). Both types of Ca^2+^ release channels are localized in the ER and in muscle in a specialized subcompartment, the SR. Other intracellular organelles that store and release Ca^2+^ include mitochondria and acidic endosomal structures. One distinct feature of the RyRs is their modification by the plant alkaloid ryanodine, hence their name, which distinguishes them from other Ca^2+^ channels. The RyRs are comprised of four polypeptides each of ∼5,000 amino acids and four FK506-binding proteins (FKBPs) each of ∼110 amino acids. RyRs are high-conductance, monovalent- and divalent-conducting channels regulated by multiple factors that include Ca^2+^, Mg^2+^, ATP, calmodulin (CaM), protein kinases and phosphatases, and redox active species. Recent determination of the high-resolution cryo-electron microscopy (cryo-EM) structure of the skeletal muscle RyR1 and cardiac muscle RyR2 isoforms has provided insight into the complex interacting regulatory mechanisms of SR Ca^2+^ release ([@bib46]; [@bib275]; [@bib280]; [@bib8]; [@bib37]; [@bib168]; [@bib253]). RyR-like structures were identified in colony-forming choanoflagellates that evolved more than 600 million years ago ([@bib133]). Alterations in the activity of the RyRs have been implicated in a number of muscle diseases. More than 100 RyR1 mutations are potentially associated in skeletal muscle with malignant hyperthermia (MH), central core disease (CCD), and multi-minicore disease (MmD; [@bib188]; [@bib239]), and more than 150 RyR2 mutations are potentially linked to catecholaminergic polymorphic ventricular tachycardia (CPVT), arrhythmogenic right ventricular dysplasia type 2 (ARVD2), and idiopathic ventricular fibrillation in cardiac muscle ([@bib70]; [@bib123]). Here, the experimental and recent structural studies that led to our current understanding of RyR regulatory mechanisms and their structural basis are reviewed.

Mechanisms of SR Ca^2+^ release in mammalian skeletal and cardiac muscle {#s03}
========================================================================

Rapid release of Ca^2+^ in striated muscle is triggered by an action potential that spreads rapidly over the surface membrane into tubular infoldings (T-tubule) of the surface membrane. A distinguishing feature is that cardiac muscle excitation--contraction (E-C) coupling depends on extracellular Ca^2+^, whereas skeletal muscle E-C coupling does not. This finding led to the formulation of two principal mechanisms for E-C coupling: the Ca^2+^-induced Ca^2+^ release (CICR) hypothesis in heart ([@bib51]) and the mechanical coupling hypothesis in vertebrate skeletal muscle ([@bib200]; [@bib187]). Voltage- and dihydropyridine-sensitive (L-type) Ca^2+^ channels (dihydropyridine receptors \[DHPRs\], Ca~v~1.2s) located in the surface membrane and T-tubule in cardiac muscle open closely apposed SR Ca^2+^ release channels (RyR2s) that result in the release of massive amounts of Ca^2+^. In contrast, in mammalian skeletal muscle, voltage-sensing L-type Ca^2+^ channels (DHPRs, Ca~v~1.1s) in the T-tubule open closely apposed SR Ca^2+^ release channels (RyR1s) through direct protein--protein interactions.

Structural arrangement of RyRs in skeletal and cardiac muscle {#s04}
=============================================================

Skeletal and cardiac muscle SRs have longitudinal (free) and junctional SRs that are structurally and functionally distinct membrane regions. Longitudinal SR is a sarcotubular network that surrounds the myofibrils and contains a Ca^2+^ pump responsible for Ca^2+^ uptake by SR. The junctional SR is mainly involved in Ca^2+^ release and houses RyR ion channels near L-type Ca^2+^ channels in the plasmalemma (RyR2) and T-tubule (RyR1 and RyR2; [@bib62]). Groupings of L-type Ca^2+^ channels and RyRs in so-called Ca^2+^ release units or couplons comprise 10--100 RyR1 in fast- and slow-twitch rat, guinea pig, frog, and toadfish skeletal muscle ([@bib63]). Large protein structures termed "feet" represent the large cytoplasmic domains of the RyR1s that span the narrow gap separating the two membranes. Morphological evidence suggests a well-defined interaction between T-tubular Ca~v~1.1 and SR RyR1 channels in skeletal muscle. Clusters of four particles, tetrads representing four Ca~v~1.1s, are located opposite four subunits of every other RyR1 ([@bib19]). The formation of Ca~v~1.1 tetrads depends on the presence of apposing RyR1s ([@bib229]; [@bib181]). However, surface membrane--SR junctions were observed in mouse skeletal muscle primary cultures lacking RyR1. This suggests that other proteins are involved in the close linkage of the two membrane systems. SR junctional proteins that assist in the formation of the triad junction include triadin ([@bib23]; [@bib82]), junctin ([@bib103]), mitsugumin 29 ([@bib231]), and STAC3 ([@bib22]).

Two populations of RyR1s in skeletal muscle, one coupled to tetrads and one not, raised the question of how unlinked RyRs are activated. One suggestion was that Ca^2+^ released by Ca~v~1.1-linked RyR1s activates Ca~v~1.1-unlinked RyR1s by a Ca^2+^-induced Ca^2+^ release mechanism seen in cardiac muscle ([@bib187]). However, CICR is slow in the presence of ATP and Mg^2+^ compared with physiological Ca^2+^ release (review by [@bib47]). Ca^2+^ did not trigger the release of Ca^2+^ in mouse permeabilized skeletal muscle in the presence of physiological concentrations of ATP and Mg^2+^, which also suggested that Ca^2+^ is not the principal activator of RyR1 ([@bib58]). On the other hand, it was proposed that Ca^2+^ may terminate the release of Ca^2+^ by binding to Ca^2+^ inactivation sites. [@bib176] observed an increase in SR Ca^2+^ release from skinned rat muscle fibers in the presence of ∼400 µM 1,2-bis(2-aminophenoxy)ethane-*N*,*N*,*N*′,*N*′-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA), a fast Ca^2+^-chelating agent. [@bib227] noted that BAPTA changed the amplitude and kinetics of Ca^2+^ release in mammalian fibers. An alternative mechanism is that neighboring RyR1s are physically and functionally linked, which leads in lipid bilayers to the simultaneous opening and closing of two or more channels, termed coupled gating ([@bib135]).

Clusters of tetrads of Ca~v~1.1s in skeletal muscle located opposite the four subunits of every other RyR1 resulted in a Ca~v~1.1/RyR1 ratio of 1.4:1.9 ([@bib16]). A ratio of less than two suggested that not all tetrads were complete, as observed in freeze-fracture studies ([@bib180]).

The location and arrangement of DHPRs and RyRs in cardiac muscle is more diverse. The Ca~v~1.2/RyR2 ratio is lower, ranging from 0.27 in rabbit to 0.1 in ferret myocytes ([@bib16]). SR junctional domains containing closely packed groupings of RyR2s that range in size from a few to several 100 RyR2s form discrete junctional domains with the surface membrane (peripheral couplings) and T-tubule (diads). In cardiac cells lacking T-tubules (e.g., conduction cells, avian hearts), junctional SR is near the surface membrane and in extended junctional SR away from the surface membrane ([@bib214]). Frog ventricle contains few if any RyRs, which suggests a reliance on calcium entry through surface membrane Ca^2+^ channels for muscle contraction ([@bib234]).

The third mammalian RyR isoform RyR3 is expressed in diaphragm and slow-twitch skeletal muscle ([@bib36]), brain and smooth muscle ([@bib66]; [@bib121]; [@bib72]), and fast-twitch skeletal muscle of young but not adult mice ([@bib60]). Two immunologically distinct high molecular weight RyR protein bands corresponding to mammalian RyR1 and RyR3 were identified in skeletal muscles from chicken ([@bib2]) and frog ([@bib165]). RyR3s in frog skeletal muscle and toadfish swim bladder are segregated in a parajunctional position adjacent to the junctional SR, where they are activated by calcium released from RyR1 channels ([@bib54]). Consistent with a low RyR3/RyR1 ratio, parajunctional feet are less frequently seen in mouse skeletal muscle and diaphragm. The appearance of the RyR1 isoform alone in some fast-contracting muscle of fish suggests that RyR1 is selectively expressed when rapid contractions are required in muscle ([@bib161]). Spontaneous or evoked activation of a few RyRs results in spatially limited Ca^2+^ release events, known as Ca^2+^ sparks ([@bib28]). Ca^2+^ sparks are observed in skeletal muscle that express RyR3, and in cardiac muscle.

Preparations for studying RyR function {#s05}
======================================

RyR function has been studied using intact and skinned fibers, fragmented SR, and purified RyR preparations. There are two ways of accessing the intracellular compartment in muscle cells without disrupting the SR membrane (review by [@bib217]). One is to mechanically remove the surface membrane from intact skeletal muscle cells. This procedure consists of physically rolling back a portion of the sarcolemma of a single fiber ([@bib158]). T-tubules will reseal in mechanically skinned fiber preparations. SR Ca^2+^ release and contraction can therefore be elicited by depolarizing T-tubule by ion substitution ([@bib41]; review by [@bib118]). [@bib52] studied the mechanism of CICR in cardiac muscle by removing the surface membrane from fragments of single cardiac cells by microdissection. To study SR Ca^2+^ release in the absence of T-tubule depolarization, muscle cells were treated with low concentrations of saponin, a detergent that disrupts cholesterol-containing membranes (surface membrane and T-tubule) but not membranes that lack cholesterol (SR). Skinned fiber studies were performed using mammalian skeletal muscle and amphibian skeletal muscle preparations that contain the RyR3 isoform, in addition to RyR1. These studies identified three principal properties of the RyRs: SR Ca^2+^ release is stimulated by Ca^2+^ and adenine nucleotides and inhibited by Mg^2+^.

Fragmentation of SR during homogenization of rabbit skeletal muscle and subsequent fractionation by differential and density centrifugation yielded "light" and "heavy" SR vesicles according to sedimentation properties ([@bib142]). Light vesicles correspond to the longitudinal SR and contain the SR Ca^2+^ pump as the major protein. Heavy SR vesicles derived from the junctional region of the SR contain "Ca^2+^ release channels" that are activated by Ca^2+^ and adenine nucleotides and inhibited by Mg^2+^ ([@bib143]; [@bib146]). Another important advance was the isolation of membrane fractions enriched in T-tubule segments sandwiched between two junctional SR compartments ([@bib150]). These junctional complexes are known as triads. Microsomal membrane fractions enriched in ryanodine-sensitive Ca^2+^ release channels were also isolated from other excitable tissues, such as cardiac muscle, smooth muscle, and brain. In these cases, however, the membrane fractions were typically of a lower purity than those from rabbit skeletal muscle.

Purification and identification of RyRs {#s06}
=======================================

Isolation of the SR Ca^2+^ release channel is facilitated by the identification of ryanodine as a channel-specific ligand ([@bib59]; [@bib171]; [@bib225]; [@bib144]). Ryanodine is toxic and has different pharmacological effects depending on muscle type and activity. Ryanodine can increase or decrease the contractile force ([@bib101]). Because the drug binds with high specificity and dissociates slowly from the high-affinity site in the receptor (either membrane-bound or detergent-solubilized), \[^3^H\]ryanodine is an ideal probe to monitor the isolation of RyRs from a variety of tissues and species.

RyRs were initially isolated from rabbit skeletal muscle SR membrane preparations as a spanning protein complex comprised of 300-kD subunits ([@bib106]) and multiprotein ryanodine-binding complexes that displayed a pharmacology ([@bib172], [@bib173]; [@bib100]; [@bib113]) and morphology characteristic of the feet structures in junctional SR ([@bib100]; [@bib114]). Insertion of rabbit skeletal muscle ([@bib211], [@bib212]) and canine cardiac muscle ([@bib190]) SR vesicles and purified \[^3^H\]ryanodine-binding protein complexes ([@bib98]; [@bib115]; [@bib213]; [@bib5]) in lipid bilayers showed that RyR1 and RyR2 are Ca^2+^- and ATP-activated, monovalent and divalent ion--conducting channels composed of four ∼565-kD polypeptides. The high molecular weight RyR polypeptide was associated with isoform-specific immunophilins (FKBPs) that migrated on SDS acrylamide gels as 12-kD proteins ([@bib34]; [@bib235]).

Cloning and sequencing rabbit, human, and pig RyR1 ([@bib230]; [@bib283]; [@bib65]), rabbit and human cardiac RyR2 ([@bib157]; [@bib164]; [@bib241]), and rabbit RyR3 ([@bib89]) revealed that the mammalian RyRs are a family of closely related Ca^2+^-conducting channels composed of four polypeptides of ∼5,000 amino acids each.

Structure of mammalian RyRs {#s07}
===========================

The morphology of purified RyRs was examined initially by negative-staining electron microscopy ([@bib106]; [@bib99],[@bib100]; [@bib115]; [@bib192]; [@bib5]). Mammalian RyR1 and RyR2 have large square, four-leaf clover structures that resemble the feet that span the T-tubule--SR gap. A more detailed understanding of the structure of the intact RyRs was revealed by cryo-EM, a method well suited to resolve the structure of macromolecular complexes in the near-native conformation. Three-dimensional reconstruction from electron micrograph data of frozen-hydrated RyR specimens at a resolution of ∼30 Å revealed a 29 × 29 × 12-nm large cytoplasmic assembly with a 7-nm-length and 8-nm-diameter transmembrane domain ([@bib245]; [@bib182]; [@bib202]). Frozen hydrated specimens at ∼10-Å resolution indicated that the closed (nonconducting; [@bib131]; [@bib195]) and open (conducting; [@bib197]) RyR1 has a pore structure characteristic of the voltage-gated ion channel family. Along with revealing the global structure, cryo-EM in combination with fluorescence resonance energy transfer (FRET) measurements identified regulatory sites on RyR1 and RyR2 such as the FKBP site ([@bib247]; [@bib204]; [@bib77]) and sites of the Ca^2+^-free and Ca^2+^-bound forms of CaM ([@bib246]; [@bib194]; [@bib95]).

Recent cryo-EM studies provide more detailed insights into the structure of intact RyRs. The closed and open pore structures of RyR1 and RyR2 were determined at 3.6- to ∼6-Å resolution ([@bib46]; [@bib275]; [@bib280]; [@bib8]; [@bib37]; [@bib168]; [@bib253]). More than two thirds of the molecular mass of RyRs was resolved. SR membranes from rabbit skeletal muscle ([@bib46]; [@bib275]; [@bib280]; [@bib8]; [@bib37]; [@bib253]) and porcine cardiac muscle ([@bib168]) were solubilized using the zwitterionic detergent 3-\[(3-cholamidopropyl)dimethylammonio\]-1-propanesulfonate (CHAPS). RyRs were purified on sucrose gradients or by affinity chromatography using glutathione-transferase--tagged FKBP12 and FKBP12.6. Closed RyR2 channels were applied to grids in buffers containing 5 mM EDTA and the nonionic detergent digitonin ([@bib168]). To obtain open channels, RyR2 was transferred to a buffer containing 20 µM Ca^2+^ and 20 µM PCB95, a RyR activator. Closed RyR1 structures were determined in buffers containing EGTA and Tween 20 ([@bib275]) or CHAPS and a low concentration of lipid ([@bib280]; [@bib37]). To obtain closed and open RyR1s, [@bib8] applied the purified RyR1 channel complex to grids in a buffer that contained Tween 20 or CHAPS, respectively. [@bib253] determined the structure of the closed RyR1 channel in a buffer containing amphipol A8-35, an amphipathic surfactant that stabilizes and maintains solubilized membrane proteins in detergent-free solutions. The open RyR1 channel was maintained in the presence of 100 µM Ca^2+^ and 10 µM ruthenium red, an RyR channel blocker. With some exceptions, retention of function of the purified RyRs was not determined. Four different channel states were obtained according to single-channel measurements that kept RyR1 in a closed state (nominal 0 µM Ca^2+^), partially open state (30 µM Ca^2+^; 0 µM Ca^2+^, 2 mM ATP, and 5 mM caffeine), or fully open state (30 µM Ca^2+^, 2 mM ATP, and 5 mM caffeine; [Fig. 1](#fig1){ref-type="fig"}). Addition of 10 µM ryanodine converted channels to an open subconducting state ([@bib37]).

![**Open RyR1 channel structure.** The structure (PDB code [5TAL](5TAL)) reveals the major domains and the location of Ca^2+^-, ATP-, and caffeine-binding sites.](JGP_201711878_Fig1){#fig1}

Determination of the high-resolution closed- and open-channel structures provides a better understanding of the mechanisms of channel gating and ion permeation and how they are altered in RyR-associated diseases. Each RyR subunit has been subdivided into ∼10 domains ([Fig. 1](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). These include (1) the N-terminal domain that is a hotspot of RyR1 and RyR2 disease mutations, (2) the SPRY1 domain that is part of the binding site for FKPB12, (3) the junctional solenoid (Jsol) and bridging solenoid (Bsol), where the latter contains PKA and Ca^2+^/CaM-dependent protein kinase II (CaMKII) phosphorylation sites, (4) the central solenoid (Csol) domain that contains two EF hand Ca^2+^ binding motifs, (5) the transmembrane domain that forms the conductance pathway for Ca^2+^, and (6) the C-terminal domain (CTD) that forms part of the Ca^2+^, ATP, and caffeine activation sites. Crystal structures of smaller RyR fragments at resolutions of \<2 Å and covering N-terminal, SPRY1, SPRY2, RY1 and 2, and RY3 and 4 domains have clarified the functional role of ligands and disease mutations ([@bib277]). A comprehensive description of the RyR1 domain structure is provided by [@bib37] and [@bib193].

###### Cryo-EM domain nomenclature of RyR1

  Domain name                Alternative names   Color[^a^](#ttbl1n1){ref-type="table-fn"}   Sequence[^b^](#ttbl1n2){ref-type="table-fn"}
  -------------------------- ------------------- ------------------------------------------- ----------------------------------------------
  N-terminal domain                              Yellow                                      1--627
  SPRY1                                          Light orange                                628--849
  RY1 and 2                  P1                  Light magenta                               850--1,054
  SPRY2 and 3                                    Light orange                                1,055--1,656
  Jsol                       Handle              Green                                       1,657--2,144
  Bsol                       HD1&2               Cyan                                        2,145--3,613
   Includes RY3 and 4        P2                  Orange                                      2,735--2,938
  Csol                       Central domain      Tomato                                      3,667--4,174
   Includes EF hand motifs                                                                   4,060--4,134
    TaF                                                                                      4,175--4,253
  Transmembrane domain                           Blue                                        4,541--4,956
  C-terminal domain                              Brown                                       4,957--5,037

Domain color in [Fig. 1](#fig1){ref-type="fig"}.

[@bib37].

Ca~v~1.1--RyR1 interactions {#s08}
===========================

A unique property of the mammalian skeletal muscle RyR1 is its direct linkage to the skeletal muscle Ca~v~1.1 channel isoform, which acts in E-C coupling as a voltage-sensing molecule rather than as a Ca^2+^ channel. Ca~v~1.1 is comprised of a pore-forming α~1~ subunit and α~2~δ, β, and γ subunits. Early death of dysgenic mice lacking the α~1~ subunit ([@bib14]) and β-null mutant mice ([@bib80]) suggested that both subunits are required for skeletal muscle E-C coupling. Several regions of Ca~v~1.1 α1 and β subunits interacted with RyR1 and vice versa (review by [@bib12]). Detailed structural information on the interaction between the intact Ca~v~1.1 and RyR1 is lacking, in part because a Ca~v~1.1--RyR1 complex has not been isolated. However, obtaining this structural information should be facilitated by the availability of the recently determined near-atomic resolution structure of the intact RyR1 ([@bib275]; [@bib280]; [@bib8]; [@bib37]; [@bib253]) and Ca~v~1.1 ([@bib257]) complexes.

RyRs are high-conductance, cation-selective channels {#s09}
====================================================

Fusion of heavy rabbit skeletal muscle vesicles with planar lipid bilayers provided the initial evidence that the SR membrane contains a calcium-conducting channel of 125 pS ([@bib211]). Channel activities recorded in the presence of Ca^2+^, ATP, and ruthenium red were compared with results obtained in vesicle flux measurements according to a rapid quench protocol. Results indicated that the 125-pS channel mediates rapid Ca^2+^- and ATP-gated release of Ca^2+^ from skeletal muscle SR vesicles. Subsequent lipid bilayer studies with canine cardiac muscle SR vesicles ([@bib190]) and purified \[^3^H\]ryanodine-binding protein complexes ([@bib98]; [@bib115]; [@bib213]; [@bib5]) established that RyR1 and RyR2 are Ca^2+^- and ATP-activated, Mg^2+^-inhibited, monovalent and divalent ion--conducting channels with a P~Ca~/P~K~ ratio of ∼7--8.

Sequence comparisons and mutagenesis studies provided evidence that the RyRs have a pore structure similar to K^+^ channels ([@bib10]; [@bib282]; [@bib69]; [@bib44]). RyR amino acid residues between the two C-terminal S5 and S6 membrane-spanning segments were suggested to be luminally located, with a pore helix and an amino acid motif (GGGIG) similar to the selectivity filter motif (TV/IGYG) of K^+^ channels. However, there are important differences among the RyRs relative to K^+^ channels. One is that RyRs conduct both monovalent and divalent cations with the following relative specificity: K^+^ \> Rb^+^ \> Na^+^ ≈ Cs^+^ \> Li^+^, and Ba^2+^ \> Sr^2+^ \> Ca^2+^ \> Mg^2+^ ([@bib126]; [@bib236]). A second difference is that single-channel measurements with permeant and impermeant organic cations suggest a wider minimum radius of 3.3--3.5 Å for RyR2 ([@bib237]) than the experimentally determined minimum radius of 1.5 Å for K^+^ channels ([@bib93]). Mutagenesis studies showed that two negatively charged amino acid residues (RyR1-D4899 and E4900) immediately after the selectivity filter motif in the luminal vestibule and two negatively charged residues (RyR1-D4938 and D4945) in the cytosolic vestibule have a critical role in RyR1 ion permeation and selectivity ([@bib250]; [@bib266]).

Construction of a RyR1-Δ183-4006 deletion mutant and C-terminal construct of 1,377 amino acid residues showed that the RyR1 C-terminal portion forms a monovalent conducting channel activated by Ca^2+^ and modified by ryanodine ([@bib17]). The two C-terminal transmembrane segments that included the pore helix and connecting loops formed a homotetrameric assembly that conducted K^+^ and Ca^2+^ and also Cl, which suggests the loss of a cation-specific pathway ([@bib50]).

Cryo-EM data support the view that RyR1 has a pore structure characteristic of the voltage-gated channel family. [@bib195] and [@bib131] determined the pore structure of the closed (nonconducting) RyR1 at a resolution of ∼10 Å. The pore-forming region as visualized by [@bib131] consisted of a long inner helix comprised of 31 amino acid residues and a pore helix of 15 residues. An increased resolution of ∼4 Å showed that Ile4937 in the S6 pore lining helix forms the hydrophobic constriction site in the closed RyR1 with a pore radius of less than 1 Å, rendering the channel impermeable to Ca^2+^ ([@bib275]; [@bib280]). In the open RyR2 state, the pore constriction site was shifted to Gln4864 (corresponding to Gln4933 in RyR1), widening the RyR2 minimal pore radius to ∼2 Å ([@bib168]). Ion-pulling simulations generated an open-channel conformation of RyR1 ([@bib153]) from the 3.8-Å closed state of RyR1 ([@bib275]). The pore constriction site at RyR1-Gln4933 had a minimum open-channel pore radius of ∼2.8 Å ([@bib153]), in reasonable agreement with the experimentally derived minimum radius of 3.3--3.5 Å ([@bib237]). The cryo-EM structure and model data suggest that channel opening involves a rotation of the upper portion of the pore-lining S6 helix away from the fourfold channel axis. [@bib253] used the RyR channel blocker ruthenium red to obtain an open channel. At variance with the aforementioned studies, Ile4937 in the closed RyR1 conferred a pore radius of 2.5 Å, which increased to 4.9 Å in the "open ruthenium-red--stabilized" channel, allowing the passage of hydrated Ca^2+^ ions.

The RyR1 S6 pore lining helix has two conserved hinge glycines (Gly4934 and Gly4941) associated with channel opening. Determination of the pore structure of the closed (nonconducting) RyR1 at a resolution of ∼10 Å suggested that the inner S6 helix has a bend at RyR1-Gly4934 ([@bib131]). [@bib197] determined the cryo-EM structure of both the open and closed RyR1. As observed for the high-resolution structures of K^+^ channels ([@bib102]), the inner helix had an outward bend on a glycine (Gly4934 or Gly4941) in the open but not closed channel. This change along with other cytoplasmic structural changes widened the radius of a cytoplasmic ion gate from ∼4 to ∼6 Å, allowing the flow of ions through the channel. Because cryo-EM had a resolution of only ∼10 Å, the positions of pore residue side chains and the structure of loops connecting the helices remained unknown ([@bib131]; [@bib197]).

The two conserved glycines were replaced with uncharged amino acid residues of an increased side chain volume. Substitution of RyR2-Gly4864 (corresponding to RyR1-Gly4934) with alanine resulted in no significant change of RyR2 function, whereas replacement with valine and proline profoundly altered channel gating and ion permeation ([@bib49]). Replacement of RyR1-Gly4934 and Gly4941 with alanine altered RyR1 channel function in single-channel measurements ([@bib141]). Mutations further increasing the side chain volume at these positions (RyR1-G4934V and G4941I) resulted in loss of function. Molecular modeling suggested that the two glycines facilitate RyR channel function by providing flexibility and minimizing amino acid clashes.

A model of RyR2 ion permeation based on Eyring rate theory postulated four potential barriers within the pore corresponding to three putative binding sites ([@bib238]). Without knowledge of the structure of the pore, the model quantitatively reproduced the conductance data of mono- and divalent cations. Cryo-EM has tentatively assigned two barriers corresponding to the selectivity filter and open-channel RyR2-Gln4864 residue. A Poisson--Nernst--Planck density functional theory model accurately modeled the role of negatively charged residues in the luminal (RyR1-Asp4899 and Glu4900; [@bib250]) and cytosolic (RyR1-Asp4938 and Asp4945; [@bib266]) vestibules of RyR1 in generating the high ion conductances of RyRs ([@bib75]). Selectivity was attributed to charge-space competition, as Ca^2+^ could accommodate the most charge in the least space compared with K^+^ ([@bib75]; [@bib73]). Although the large dehydration energy but high conductance of Mg^2+^ suggest that ion dehydration does not play a major role in RyR ion permeation ([@bib76]), the exact hydration states of Ca^2+^ ions remain to be determined as they pass through the pore. [@bib74] predicted that RyR ion channels must mediate their own K^+^ countercurrents to minimize the formation of a membrane potential during SR Ca^2+^ release that would otherwise rapidly impede further release of Ca^2+^.

Regulation of RyRs by Ca^2+^ {#s10}
============================

The mechanism of skeletal muscle and cardiac SR Ca^2+^ release has been extensively studied using isolated SR membrane and purified RyR preparations by applying three complementary methods. Macroscopic ion fluxes were measured from actively or passively loaded SR vesicles using rapid flow, quench, and filtration protocols. Microscopic monovalent ion and Ca^2+^ currents were recorded through single Ca^2+^ release channels incorporated into lipid bilayers ([Fig. 2](#fig2){ref-type="fig"}). In a widely used but less direct method, RyR channel activity was probed using the specific plant alkaloid ryanodine ([@bib226]; [Fig. 2](#fig2){ref-type="fig"}). All three methods showed that RyRs are activated by micromolar Ca^2+^ and millimolar ATP and are inhibited by millimolar Mg^2+^ and Ca^2+^.

![**Ca^2+^ dependence of RyR1.** Data obtained using the planar lipid bilayer and \[^3^H\]ryanodine binding methods. With modifications from [@bib91].](JGP_201711878_Fig2){#fig2}

Evidence for cytosolic RyR sites involved in Ca^2+^ activation {#s11}
--------------------------------------------------------------

RyRs are activated by micromolar cytosolic Ca^2+^ and inhibited by millimolar cytosolic Ca^2+^ in the absence of other channel effectors. A biphasic behavior implies there are at least two classes of Ca^2+^-binding sites: a high-affinity activation site and a low-affinity inactivation site. However, differences in Ca^2+^ regulation of the mammalian RyR isoforms have been observed. In single-channel measurements, RyR2 and RyR3 isoforms are activated to a greater extent by cytosolic Ca^2+^ than RyR1 and require higher cytosolic Ca^2+^ concentrations to be inhibited when Ca^2+^ is the sole activating ligand ([Fig. 3](#fig3){ref-type="fig"}). Similarly, in avian and amphibian skeletal muscle that express both mammalian RyR1 and RyR3 homologues, RyR3 is activated by Ca^2+^ to a greater extent than RyR1 ([@bib169]; [@bib154]).

![**Ca^2+^ dependence of single purified RyR1, RyR2, and RyR3.** Shown are channel P~o~ values as a function of cytosolic free Ca^2+^ in 250 mM K^+^, pH 7.4 medium. Redrawn from [@bib265]; (RyR1 and RyR2) and [@bib25]; (RyR3).](JGP_201711878_Fig3){#fig3}

Comparison of cryo-EM maps prepared in the absence or presence of 30 µM Ca^2+^ revealed a Ca^2+^-binding site at the interdomain interfaces of the RyR1 Csol and C-terminal domains ([@bib37]). The site encompasses three amino acids conserved among the RyR and IP~3~R families directly interacting with Ca^2+^, RyR1-Glu3893, and Glu3967 of the Csol and Thr5001 of the C-terminal domain ([Fig. 4 A](#fig4){ref-type="fig"}). Two amino acids, Gln3970 and His3895, indirectly interact with Ca^2+^. The channel apparently remains closed with 30 µM Ca^2+^ as the sole activating ligand, even though single-channel measurements showed a channel open probability (P~o~) of 0.22. Similarly, opposite results were obtained using ATP and caffeine alone, whereas the three ligands Ca^2+^, ATP, and caffeine opened the channel in the structural and single-channel studies. [@bib37] proposed that Ca^2+^ or ATP/caffeine alone primed the channel for opening, but all three ligands were required to overcome a barrier for opening. An alternative explanation is that the number of open channels under the conditions of Ca^2+^ or ATP/caffeine was too low to be scored as a separate class.

![**Structure of regulatory sites in RyR1.** Ca^2+^ (A)-, ATP (B)-, and caffeine (C)-binding sites of open RyR1 (PDB code [5TAL](5TAL)).](JGP_201711878_Fig4){#fig4}

Mutagenesis has indicated that additional regions are involved in the regulation of RyRs by Ca^2+^. In one early study, RyR1-Δ183-4006 deletion mutant was activated by micromolar Ca^2+^, which suggests a Ca^2+^-binding site different from the one identified by cryo-EM ([@bib17]). Substitution of RyR1-Glu4032 by alanine and the corresponding amino acid residue in the RyR3 isoform reduced Ca^2+^-gated channel activity ([@bib26]; [@bib42]; [@bib56]). However, RyR1-Glu4032 was not a part of a Ca^2+^-binding site, but rather stabilized the interaction between two RyR1 regions ([@bib37]). Other examples include CCD mutations located in the pore-forming region of RyR1 in skeletal muscle ([@bib139]; [@bib40]; [@bib267]), sites in S2 ([@bib78]), S4--S5 linker ([@bib155]; [@bib183]), N-terminal region of RyR2 ([@bib130]), and S6 of RyR2 ([@bib220]). Taken together, both structural and functional studies indicate that the transition of the closed to Ca^2+^-activated open channel involves the coordinated motion of multiple regions outside the Ca^2+^-binding site.

Evidence for cytosolic RyR sites involved in Ca^2+^ inactivation {#s12}
----------------------------------------------------------------

[@bib46] compared two RyR1 cryo-EM structures in the absence of Ca^2+^ and at 10 mM Ca^2+^ at a resolution of 6.1 Å. Differences in the Ca^2+^-free and Ca^2+^-bound maps were interpreted to indicate that binding of Ca^2+^ to a two--EF hand motif in the Csol domain ([Fig. 1](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}) increased the mean gate diameter, which indicated formation of an open channel. However, functional studies were not presented. Moreover, the addition of 10 mM Ca^2+^ results in a nearly fully closed and not open RyR1 channel ([Fig. 3](#fig3){ref-type="fig"}). Therefore, it seems that Ca^2+^ ions bound to sites involved in Ca^2+^ inactivation and not activation of RyR1.

Earlier \[^3^H\]ryanodine binding studies with RyR1/RyR2 chimeras suggested that Ca^2+^ inactivation sites are located in the C-terminal quarter of RyR1 ([@bib43]). In this region, two EF1 and EF2 hand motifs are located in a CaM-like domain of RyR1 (amino acids 4,064--4,210; [@bib261]). A peptide corresponding to the CaM-like domain bound Ca^2+^ with an apparent affinity of 60 µM ([@bib261]). Two smaller recombinant proteins from rabbit skeletal muscle RyR1 (amino acids 4,069--4,139), cardiac muscle RyR2 (amino acids 4,025--4,095), and lobster skeletal muscle containing the two EF hand motifs bound two Ca^2+^ with millimolar affinities, implying that sites in these regions have an inhibitory role ([@bib260]). Deletion and mutations of the two--EF hand motif in the full-length RyR2 suggested that the EF-hand domain has a role in RyR2 regulation by luminal Ca^2+^ but is not required for activation by cytosolic Ca^2+^ ([@bib83]). [@bib57] assessed the functional significance of five potential Ca^2+^ regulatory sites in RyR1, taking into account that, in addition to the two--EF hand motifs, there are three negatively charged EF-hand-like sequences encompassing amino acid residues 4,253--4,264, 4,407--4,416, and 4,489--4,499. Mutagenesis of the five motifs in RyR1 did not reveal major functional differences in response to depolarization or caffeine compared with wild-type RyR1-expressing myotubes ([@bib57]). However, in a binding assay using the RyR specific ligand \[^3^H\]ryanodine, a mutant with a scrambled EF1 hand motif exhibited altered Ca^2+^ activation and inactivation. In a scrambled EF2 hand mutant, \[^3^H\]ryanodine binding was lost, but Ca^2+^-dependent activity was maintained in single-channel recordings. Studying a large number of RyR1/RyR2 chimeras, [@bib78] found that two RyR regions are involved in Ca^2+^-dependent inactivation, one region containing the two--EF hand motifs and a second that included the S2 transmembrane segment. Among the two--EF hand motifs, EF1 more strongly controlled the isoform-specific inactivation of the RyRs by Ca^2+^.

Evidence for luminal RyR sites involved in regulation by luminal Ca^2+^ {#s13}
-----------------------------------------------------------------------

Both cytosolic and luminal Ca^2+^ regulate RyRs. Accordingly, dependence of channel activity on Ca^2+^ has suggested the presence of at least three types of Ca^2+^-binding sites, high-affinity (activating) and low-affinity (inactivating) sites accessible from the cytosol in large cytosolic foot region of the RyRs, and luminal Ca^2+^-binding sites, whose occupancy in skeletal and cardiac muscle depends on SR Ca^2+^ load ([@bib61]; [@bib53]; [@bib203]; [@bib86]).

Single-channel measurements suggest two mechanisms to explain the regulation of RyRs by luminal Ca^2+^. Luminal Ca^2+^ ions access luminal Ca^2+^-sensing channel sites of RyR1 ([@bib210]) and RyR2 ([@bib209]; [@bib85]; [@bib67], [@bib68]; [@bib39]) or bind to cytosolic sites during or after their passage through the open channel (see next section below). Evidence for the presence of luminal Ca^2+^ regulatory sites was obtained in single-channel recordings performed in the presence of cytosolic agonists ATP, caffeine, or sulmazole. Channels recorded in the presence of sulmazole or ATP were activated to a greater extent by luminal Ca^2+^ under voltage conditions that suggested a luminal-to-cytosolic flow through the channel ([@bib209], [@bib210]). Differences in the number of channel events and the duration of open and closed events suggested that binding of ATP or sulmazole to cytosolic channel sites uncovered luminal Ca^2+^-binding sites. [@bib39] compared the regulation of RyR2 by luminal Mg^2+^, Ca^2+^, Sr^2+^, and Ba^2+^. RyR2 activation depended on cytosolic Ca^2+^ and caffeine concentrations. Although a greater activation by divalent cations compared with Cs^+^ was observed in the absence of caffeine at 100 μM cytosolic Ca^2+^, caffeine was required at 100 nM cytosolic Ca^2+^ for luminal Ca^2+^ and Sr^2+^ (but not Mg^2+^ and Ba^2+^) to activate RyR2 ([@bib39]). This suggested the presence of two luminal activating cation-binding sites, one specific for Ca^2+^ and another that bound Ca^2+^ and Mg^2+^. [@bib68] reported that at 100 nM cytosolic Ca^2+^ and millimolar caffeine, RyR2 was fully activated by luminal Ca^2+^ and Sr^2+^. Higher caffeine concentrations were required for full activation by luminal Mg^2+^ and Ba^2+^. A luminal S1-S2 EF hand--related loop region was suggested to bind with an affinity of Ca^2+^ \> Sr^2+^ \>Mg^2+^ ≈ Ba^2+^.

A "store overload-induced Ca^2+^ release" (SOICR) in cardiac muscle can generate Ca^2+^ waves and Ca^2+^-triggered arrhythmias. Loss of luminal Ca^2+^ activation suggested the presence of a luminal regulatory site ([@bib105]). A point mutation in RyR2 (RyR2-E4872A corresponding to RyR1-E4942A) eliminated Ca^2+^ regulation by luminal Ca^2+^ but not by cytosolic Ca^2+^. In mouse hearts, the RyR2-E4872 mutation suppressed SOICR and Ca^2+^ triggered ventricular tachycardia ([@bib27]).

Evidence for cytosolic RyR sites involved in regulation by luminal Ca^2+^ {#s14}
-------------------------------------------------------------------------

An alternative suggestion is that luminal Ca^2+^ regulates RyRs by binding to cytosolic regulatory sites after their passage through the open channel (also referred to as feed-through; [@bib92]; [@bib240]; [@bib262]; [@bib242]). To distinguish luminal and cytosolic Ca^2+^ regulatory sites, voltage- and Ca^2+^-dependent regulation of single RyR1 channels was reported ([@bib240]). Single channels were partially opened by cytosolic ATP in the presence of low cytosolic Ca^2+^. As luminal Ca^2+^ was increased to micromolar concentrations, increasing channel activity was initially only seen at negative holding potentials that supported a luminal-to-cytosolic flow through the channels. A further increase in luminal Ca^2+^ to millimolar levels resulted in a decrease in channel activity. The results suggested that luminal Ca^2+^ flowing through the skeletal muscle Ca^2+^ release channel regulates channel activity by accessing cytosolic Ca^2+^ activation and inactivation sites.

A possible resolution of the different mechanisms proposed for the luminal regulation of RyRs is that it involves Ca^2+^ sensing sites on both the luminal and cytosolic channel sites ([@bib120]). Modeling of single ATP-activated RyR2 channel activities indicated four Ca^2+^ regulatory sites: luminal (L) activation site, cytosolic activation (A) site, and cytosolic high-affinity (I~2~) and low-affinity (I~1~) inactivation sites. Luminal Mg^2+^ inhibited RyR2 by competing for Ca^2+^ at the L and A sites and binding to the I~1~ site. As discussed later, luminal Ca^2+^ also regulates RyRs by binding calsequestrin (CSQ), a low-affinity, high-capacity luminal Ca^2+^-binding protein.

Regulation by Mg^2+^ {#s15}
====================

Mg^2+^ is thought to inhibit RyRs by (a) competing with Ca^2+^ for a high-affinity cytosolic Ca^2+^ activation site, (b) binding with similar affinity as Ca^2+^ to a low-affinity cytosolic Ca^2+^ inhibitory site, (c) binding to luminal regulatory sites, and (d) reducing the flow of Ca^2+^ through the channel ([@bib146], [@bib147]; [@bib212]; [@bib84]; [@bib120]). Mg^2+^ also has an "activating" effect. Suppression of rat RyR2 and recombinant rabbit RyR2 activities at 10--100 µM Ca^2+^ was relieved by Mg^2+^ in \[^3^H\]ryanodine binding assays ([@bib32]; [@bib78]). As discussed later, Mg^2+^ forms a MgATP complex that modulates the regulation of the RyRs by Ca^2+^.

Regulation by other divalent and trivalent cations {#s16}
==================================================

High-resolution cryo-EM identified a C~2~H~2~-type Zn^2+^ finger motif formed by two cysteine (RyR1-Cys4958, Cys4961) and two histidine (RyR1-His4978, His4983) residues in the C-terminal domain of RyR1 and RyR2 ([@bib275]; [@bib168]). Although total intracellular Zn^2+^ concentrations are relatively high, the presence of a large number of cellular Zn^2+^-binding proteins yields a free Zn^2+^ concentration in the picomolar to nanomolar range ([@bib35]). Binding of Zn^2+^ affects RyR2 activity in the absence or presence of Ca^2+^ ([@bib255]). In single-channel measurements, picomolar to micromolar Zn^2+^ increased RyR2 channel open probability in a Ca^2+^-dependent manner, whereas millimolar Zn^2+^ inhibited RyR2. Mutagenesis studies showed that two cysteines in the Zn^2+^ finger motif are critical in maintaining a stable RyR1 channel conformation ([@bib96]). Expression of RyR1-C4958S or C4961S mutants restored Ca~v~1.1 currents in dyspedic myotubes, which indicated restoration of bidirectional coupling between RyR1 and Ca~v~1.1 ([@bib206]). The two mutants did not restore E-C coupling or the response to RyR1 agonists, but supported RyR1 conformation-sensitive excitation--coupled Ca^2+^ entry (ECCE) that upon depolarization was mediated by three interacting Ca^2+^ channels, Ca~v~1.1, RyR1, and a SOCE-like channel. Mutagenesis of RyR2-Cys4888, Cys4891, and His4908 eliminated caffeine activation of RyR2 ([@bib168]).

Among nonphysiological ions tested, Sr^2+^ was optimal in activating RyR2 at 1 mM, whereas Ba^2+^ did not activate RyR2 ([@bib129]; [@bib39]). Both inhibited RyR1 and RyR2 at high millimolar concentrations ([@bib147]; [@bib39]). Fe^2+^ but not Fe^3+^ inhibited \[^3^H\]ryanodine binding by competing with Ca^2+^ for the RyR2 Ca^2+^ activation site ([@bib108]). Lanthanides (Tb^3+^, Eu^3+^, Sm^3+^) are nonconducting ions that activated or inactivated RyR1 at submicromolar to micromolar levels by binding to cytosolic high-affinity Ca^2+^ activating and low-affinity Ca^2+^ inactivating sites ([@bib87]; [@bib198]). Voltage-dependent regulation by cytosolic Eu^3+^ suggested that lanthanides bind to cytosolic activating Ca^2+^-binding sites in the electrical field of the channel, whereas the inactivating sites are located outside the electrical field ([@bib198]).

Regulation by monovalent cations and anions {#s17}
===========================================

Nonphysiological assay media have been used to study RyR function. These include 50 mM CaHEPES/TrisHEPES or 0.25 M cesium methanesulfonate in single-channel measurements with SR membrane preparations to suppress SR K^+^ and Cl^−^ channel activities, or 0.25 M KCl in \[^3^H\]ryanodine binding studies or single-channel measurements with purified RyR preparations. However, RyR activities are greatly affected by the ionic composition and strength of the assay medium. An increase in KCl or NaCl stimulated Ca^2+^ release from SR vesicles and increased \[^3^H\]ryanodine binding and single-channel P~o~ ([@bib149]; [@bib31]; [@bib162]; [@bib147]; [@bib129]). Using the \[^3^H\]ryanodine ligand binding assay, RyR1 and RyR2 Ca^2+^-dependent channel activities were oppositely affected by (a) the competitive binding of monovalent cations to high-affinity Ca^2+^ activating binding sites, and (b) binding of Cl^−^ to unknown anion activating sites ([@bib147]; [@bib129]).

Regulation by adenine nucleotides {#s18}
=================================

Comparison of cryo-EM maps prepared in the absence or presence ATP and caffeine revealed an ATP-binding site at the cytoplasmic extension of S6 and elements of the C-terminal domain ([@bib37]). The site encompasses eight RyR1 amino acids. The adenine base of ATP contacts RyR1-Met4954, Phe4959, Thr4979, and Leu4985; the ribose ring of ATP likely interacts with Glu4955; and the triphosphate tail of ATP with positively charged Lys4211, Lys4214, and Arg4215 ([Fig. 4 B](#fig4){ref-type="fig"}). Channels apparently remained closed in the presence of ATP and caffeine as the sole activating ligands, even though single-channel measurements showed a channel P~o~ of 0.13. [@bib37] proposed that, similar to Ca^2+^ alone, ATP/caffeine alone primed the channel for opening, and that in addition, Ca^2+^ was required to open RyR1. Cross-linking studies using 2-azidoadenosine 5′-trisphosphate 2′3′-biotin-long-chain-hydrazone identified four glycine-rich consensus motifs in the N-terminal 95-kD fragment of RyR1, which suggests there may be additional nucleotide-binding sites ([@bib175]).

Ca^2+^ and Mg^2+^ greatly affect the activation of RyRs by ATP. In single-channel measurements in the absence of cytosolic Ca^2+^ and Mg^2+^, millimolar ATP weakly activated the essentially closed RyR1 ([@bib240]) and RyR2 ([@bib107]). On the other hand, RyR1 and RyR2 were nearly fully activated by ATP in the presence of micromolar Ca^2+^. Other adenine nucleotides such as ADP, AMP, adenosine, or adenine enhanced the release of Ca^2+^ from skeletal muscle SR vesicles ([@bib152]; [@bib143]) with a decreased potency compared with AMP-PCP ([@bib143]). In single channel measurements, ADP was less effective in activating RyR2 than ATP ([@bib107]). Other nucleotides such as CTP, GTP, ITP, or UTP had no substantial effect on the release of Ca^2+^ ([@bib152]; [@bib143]).

Most cellular ATP is present as MgATP complex that represents the predominant biologically active form of ATP in cells. An increase in Mg^2+^ that increases MgATP and decreases uncomplexed ATP decreased RyR activity ([@bib146]; [@bib264]; [@bib249]). However, whether MgATP or ATP is a physiological regulator of RyRs is unclear. In support of an interaction with "free" ATP is that ATP activates RyRs in the absence of Mg^2+^, and three positively charged amino acid residues in the ATP-binding site complement the negatively charged triphosphate tail of ATP. Experimental evidence whether ATP or MgATP is the preferred physiological regulator of RyR was not obtained by [@bib37] because the cryo-EM studies were done in the absence of Mg^2+^~.~

Regulation of RyRs by posttranslational modifications {#s19}
=====================================================

In addition to the regulation by Ca^2+^ and other small molecules, RyRs are regulated by posttranslational modifications involving phosphorylation and redox modification of sites in the large cytosolic domain of the RyRs.

RyR cysteine redox modifications {#s20}
--------------------------------

RyRs contain a large number of amino acid residues that are potential targets for reactive oxygen and nitrogen molecules generated in working muscle under physiological or pathological conditions. These include free thiols, amines, and tyrosines. Most attention has been directed toward the role of cysteines and their modification by redox active molecules. RyRs contain a large number of cysteines: 100 in RyR1 and 89 in RyR2 subunit, and 1 in FKBP12 and 2 in FKBP12.6. It is therefore not surprising that cysteines are involved in the regulation of RyR activity.

RyRs have been studied extensively in ambient O~2~ tension (pO~2~ ∼150 mm Hg), often in the absence of a reducing agent. However, muscle pO~2~ is ∼10 mm Hg, and muscle cells have a high ratio of reduced to oxidized glutathione (GSH). Use of the lipophilic thiol--specific probe monobromobimane indicated that nearly half of the 100 cysteines in the RyR1 subunit were free in the presence of 5 mM reduced GSH at pO~2~ ∼10 mm Hg ([@bib48]). An increase in oxygen tension from ∼10 mm Hg to ambient air (pO~2~ ∼150 mm Hg) in the presence of 5 mM GSH resulted in loss of 6--8 free thiols/RyR1 subunit. Substitution of GSH with oxidized GSH (GSH disulfide \[GSSG\]) at pO~2~ ∼10 mm Hg or ambient air reduced the number of free thiols/RyR1 subunit to ∼26 and increased RyR1 activity ([@bib222]). The number of free thiols in RyR2-enriched fractions in the presence of 5 mM GSH was 58 cysteines /mg protein at pO~2~ ∼10 mm Hg and 50 cysteines/mg protein at ∼150 mm Hg ([@bib223]). In the presence of 5 mM GSSG, a lower number of free cysteines was measured. However, because RyR2 was only partially purified, the exact number of GSH- and pO~2~-sensitive thiols in native RyR2 remains to be determined. The results suggest that RyR1 and RyR2 have functional thiols that respond to cellular pO~2~ and the GSH/GSSG redox state.

Treatment of SR vesicles with reduced GSH at pO~2~ ∼150 mm Hg and mass spectrometric analysis of tryptic fragments showed that monobromobimane reacted with 40 cysteines in the majority of experiments, with 20 additional monobromobimane reactive cysteines less often detected ([@bib174]). Seven RyR1 cysteines (Cys1040, 1303, 2436, 2565, 2606, 2611, and 3635) were selectively labeled by 7-diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin under conditions that led to loss of RyR1 redox sensitivity ([@bib244]). Nine RyR1 cysteines (Cys36, 315, 811, 906, 1591, 2326, 2363, 3193, and 3635) were endogenously modified, and another three cysteines (Cys253, 1040, and 1303) were modified by exogenous reactive oxygen and nitrogen molecules ([@bib6]). [@bib224] identified 13 oxygen tension-sensitive cysteines (Cys36, 566, 762, 845/854, 1674, 2305/2310, 2555, 2606, 2611, 2704, and 4238). Another eight cysteines (Cys120, 253, 305, 490, 1686, 2021, 3892, and 4663) were oxidized by an NADH oxidase at high pO~2~.

Mutagenesis studies have shown that cysteines located in the Jsol and Bsol domains and a poorly resolved region of RyR1 ([@bib37]) may serve a redox regulatory function. Substitution of cysteines with serine or alanine identified three cysteines (Cys1781, 2436, and 2606) that responded to a change in GSH redox potential ([@bib174]). At physiological O~2~ concentrations, nitric oxide (NO) specifically *S*-nitrosylated Cys3635 ([@bib221]). Cys3635 is part of the high-affinity CaM-binding domain of RyR1, which provides an explanation for the observation that NO was effective only in the presence of CaM. In addition, mutagenesis of Cys4958 and Cys4961 in C~2~H~2~-type Zn^2+^ finger motif of RyR1 resulted in an inactive channel, which supported a depolarization-dependent Ca^2+^ entry mechanism ([@bib96]). Mutagenesis of RyR2-Cys4888 and Cys4891 eliminated caffeine activation of RyR2 ([@bib168]).

RyR phosphorylation {#s21}
-------------------

The large cytoplasmic foot region of RyRs has many potential phosphorylation sites ([@bib230]; [@bib283]) that may be targeted by protein kinases and phosphatases including PKA, CaMKII, and phosphatases 2A (PP2A), PP1, and PP2B ([@bib94]; [@bib136], [@bib137]; [@bib45]; [@bib208]). RyR1 has one and RyR2 has three well-established phosphorylation sites per RyR subunit. Early studies indicated that canine RyR2-Ser2809 is phosphorylated by CaMKII and by PKA to a lesser extent ([@bib254]). Subsequent studies showed that cAMP-activated kinase (PKA) phosphorylates Ser2843 in rabbit RyR1 ([@bib219]), mouse RyR2 at Ser2030 ([@bib258]), and human RyR2 at Ser2808 ([@bib136]). CaMKII uniquely phosphorylated recombinant RyR2 at Ser2815 ([@bib251]). RyR1 was phosphorylated at Ser2843 (corresponding to Ser2809 in RyR2) by cAMP-, cGMP-, and CaMKs ([@bib219]). Phosphorylation of threonine ([@bib219]) and different functional effects of CaMKII, PKA, and cGMP-dependent protein kinase ([@bib228]; [@bib88]) suggested the presence of additional phosphorylation sites.

Phosphorylation of rabbit RyR2-Ser2809 in the P2 domain induced a more flexible conformation that favored the transition from the closed to open channel states ([@bib38]). Crystal structures of the P2 domain of RyR1 (amino acids 2,734--2,940; [@bib205]; [@bib278]) and the corresponding P2 domains of RyR2 and RyR3 ([@bib278]) have been reported. In vitro phosphorylation showed that PKA phosphorylated four residues corresponding to human residues Ser2808, Thr2810, Ser2811, and Ser2814 in the RyR2 P2 domain peptide ([@bib278]). CaMKII also phosphorylated four residues (but Thr2876 instead of Thr2810).

RyR phosphorylation has been linked to the impairment of SR function leading to heart failure. Increased sensitivity to luminal Ca^2+^ of phospho-mimicking mutant RyR2-S2030D suggested that phosphorylation of Ser2030 is involved in stress-induced cardiac arrhythmias ([@bib259]). Creation of genetically modified mouse models indicated that CaMKII phosphorylation of RyR2 at Ser2814 increases SR Ca^2+^ leak, ventricular arrhythmias, and heart failure ([@bib243]; [@bib186]; [@bib125]). PKA-mediated phosphorylation of RyR1 ([@bib185]) and RyR2 ([@bib136]; [@bib252]) led to leaky channels by dissociating the small FKBP subunit from the channel complexes, which resulted in defective RyR2 regulation. However, other studies have challenged these findings ([@bib216]; [@bib258]; [@bib4]). A recent study indicates complex PKA phosphorylation-mediated regulation of RyR2-Ser2809. Both the complete loss of phosphorylation or maximal phosphorylation of Ser2809 increased the SR leak in rabbit ventricular myocytes ([@bib20]).

Modulation of RyR activity by accessory proteins {#s22}
================================================

RyR activity is affected by a large number of proteins that interact with the RyRs, such as the FKBPs, CaM, S1001, triadin, junctin, and anchoring proteins for kinases and phosphatases.

FKBPs {#s23}
-----

The small 12- and 12.6-kD FKBPs are predominantly associated with RyR1 and RyR2, respectively ([@bib117]) and are generally considered part of the massive RyR complexes. FKBPs belong to the family of immunophilins and exhibit cis/trans isomerase activity, and their pharmacological removal using rapamycin or FK506 functionally uncouples groups of channels and increases channel activity ([@bib21]). Dissociation of FKBPs induced the formation of substates in single-channel measurements ([@bib21]; [@bib132]; [@bib1]), whereas in other studies, full conductance was maintained ([@bib13]; [@bib140]). Cryo-EM studies located FKBP12 (fused to GSH S-transferase) to a relatively large area of RyR1 ([@bib247]), which in subsequent studies was narrowed to a site at the interface of three peripheral domains corresponding to the SPRY1, SPRY3, and Jsol domains ([@bib196]; [@bib204]). Crystal structure analysis of the RyR2-SPRY1 domain along with FRET and mutagenesis studies and docking to cryo-EM maps suggested FKBP binding to a hydrophobic cluster within SPRY1 ([@bib279]).

CaM {#s24}
---

CaM is a 16.7-kD cytosolic protein that regulates SR Ca^2+^ release by direct binding to RyRs and through other proteins that interact with RyRs and bind CaM. Other major contributors are the voltage-regulated surface membrane Ca^2+^ channels (Ca~v~1s), CaM-dependent protein kinase (CaMKII), and CaM-stimulated protein phosphatase (calcineurin). CaM inhibits all three mammalian RyR isoforms at free \[Ca^2+^\] \>1 µM. At low free Ca^2+^ concentrations (*\<*1 µM), CaM activates RyR1 and RyR3 channel activity, whereas RyR2 is inhibited by CaM ([@bib97]; [@bib64]; [@bib11]; [@bib271]). RyR1 and RyR2 bind with nanomolar affinity 1 apoCaM (Ca^2+^-free form of CaM) or 1 CaCaM (Ca^2+^-bound form of CaM) per RyR subunit ([@bib11]; [@bib271]).

Trypsin digestion and site-directed mutagenesis demonstrated that RyRs have a single conserved high-affinity CaM-binding domain per RyR subunit (RyR1 amino acids 3,614--3,643, RyR2 amino acids 3,581--3,610, and RyR3 amino acids 3,467--3,498) that interacts with Ca^2+^-free or Ca^2+^-bound forms of CaM ([@bib151]; [@bib189]; [@bib269], [@bib270], [@bib271]). Crystal structure, nuclear magnetic resonance, and FRET data showed that the CaM-binding domain binds both CaM lobes in a complex formed by CaCaM and peptide corresponding to the CaM-binding domain of RyR1 ([@bib138]). Alternatively, CaCaM bound only the C-lobe, with the N-lobe potentially binding to another RyR1 region. This may explain why several RyR1 CaCaM- and apoCaM-binding sites were observed, using synthetic peptides and fusion proteins ([@bib24]; [@bib81]; [@bib119]). Studies with RyR1/RyR2 chimeras and mutants indicated that N-terminal sites and two predicted Ca^2+^ binding motifs (EF1 RyR1-4081-4092 and EF2 RyR1-4116-4127) are involved in the isoform-specific regulation by CaM at less than 1 µM Ca^2+^ ([@bib268]). Determination of temperature dependence of CaM binding showed major differences in the energetics of CaM binding to and CaM dissociation from RyR1 and RyR2 ([@bib148]).

Cryo-EM studies with RyR1 suggest that the CaM-binding site is at least 10 nm away from the transmembrane channel of the receptor and that Ca^2+^ binding to CaM (and RyR1) causes an ∼33-Å shift of the binding site ([@bib246]; [@bib194]). CaCaM is located in clefts formed by structural domains corresponding to the Jsol (amino acids 1,657--2,144) and Bsol (amino acids 2,145--3,613) domains, with the latter domain located close to the high-affinity CaM-binding site ([@bib248]). The sequence corresponding to the high-affinity CaM-binding domain was not sufficiently resolved in high-resolution cryo-EM studies to reveal its structure in intact RyRs ([@bib37]; [@bib168]).

Studies with RyR1 CaM-deficient mutants suggest a modest role for CaM regulation of RyR1 in skeletal muscle ([@bib273]). In contrast, dysfunctional regulation of RyR2 by CaM alters cardiac function. Mutations in CaM are associated with RyR2-mediated cardiac arrhythmias ([@bib160]; [@bib215]). Substitution of three amino acids in the CaM-binding domain (RyR2-W3587A/L3591D/F3603A) impaired CaM inhibition of RyR2 at diastolic and systolic Ca^2+^ concentrations. In mice, the mutations caused severe cardiac hypertrophy and death 2--3 wks after birth ([@bib272]). In contrast, mice with a single amino acid mutation in the CaM-binding domain (RyR2-L3591D) showed loss of CaM inhibition of RyR2 at diastolic but not systolic Ca^2+^, had a normal lifespan, and had only modest changes in heart size and function ([@bib274]). This was an unexpected finding because a leaky RyR2 at diastolic Ca^2+^ is commonly implicated in cardiomyopathies. In support of a role of CaM in terminating SR Ca^2+^ release, CaM prolonged the closed durations of RyR2 in the presence of ATP and Mg^2+^, allowing Ca^2+^ to diffuse away from the release sites and eliminating reopening of these channels by Ca^2+^ ([@bib263]).

S100A1 {#s25}
------

S100A1 is a small Ca^2+^-binding protein that modulates the activity of multiple Ca^2+^-handling proteins in skeletal and cardiac muscle. S100A1 modulated striated muscle function by binding to the CaM-binding domain of RyR1 ([@bib179]; [@bib256]). S100A1 inhibited RyR2 but not the single-site mutant RyR2-L3591D of the RyR2 CaM-binding domain in single-channel measurements ([@bib274]). A more recent FRET study suggested that CaM and S100A1 can concurrently modulate RyR1 and RyR2 function without S100A1 competing for CaM at the RyR CaM-binding site ([@bib184]).

Other RyR accessory proteins {#s26}
----------------------------

RyRs interact with a large number of additional proteins such as triadin, junctin, CSQ, anchoring proteins for kinases and phosphatases, and homer proteins. RyR interacting sites for these proteins have been described. The RyRs form a junctional quaternary complex with triadin, junctin, and CSQ. Triadin and junctin have a single transmembrane-spanning domain and interact directly with the RyRs. Redox-sensitive cysteines on RyR1 and triadin have a role in regulating RyR1 function ([@bib127]). Three positively charged lysines in full-length 95-kD triadin bind to three negatively charged RyR1 residues located in S5 pore helix (RyR1-Asp4878) and S6 pore helix (Asp4907, Glu4908) linkers ([@bib122]; [@bib79]). Junctin-binding sites are less well defined. Different junctin domains may bind to cytosolic and luminal sites ([@bib3]; [@bib124]).

CSQ is a low-affinity, high-capacity Ca^2+^ storage protein ([@bib134]) concentrated in the heavy vesicle fraction derived from the SR terminal cisternae of skeletal muscle ([@bib142]). Cloning studies indicated the presence of two CSQ isoforms ([@bib284]). CSQ1 is present in fast-twitch skeletal muscle and CSQ2 in cardiac muscle. Both CSQ isoforms are expressed in slow-twitch skeletal muscle ([@bib7]; [@bib18]; [@bib156]). The two isoforms contain a large number of negatively charged aspartic and glutamic acid residues, with CSQ2 having an extended negatively charged C terminus. Association with the RyR complex involved the binding of triadin and junctin KEKE motifs ([@bib82]; [@bib281]; [@bib111]) to asparagine-rich regions in the C terminus of CSQ ([@bib207]; [@bib15]). CSQs formed linear polymers ([@bib166]) and dissociated ([@bib281]) from their binding proteins as the Ca^2+^ concentration increased.

In addition to increasing Ca^2+^ store size, CSQ modulates RyR channel activity. A deficiency in SR luminal cardiac CSQ in humans ([@bib177]; [@bib112]), mice ([@bib110]), and cardiomyocytes ([@bib232]) resulted in an imbalance of Ca^2+^ handling and CPVT. Overexpression of CSQ2 suppressed SR Ca^2+^ transients and led to severe cardiac hypertrophy in mice ([@bib104]; [@bib199]; [@bib232]). Abnormal Ca^2+^ handling in association with cardiac myopathies was also observed in mice and cardiomyocytes that lacked or overexpressed the RyR2-accessory proteins triadin and junctin ([@bib71]; [@bib109]; [@bib276]; [@bib30]).

[@bib137] identified several anchoring proteins that mediate an interaction between RyR2 and accessory kinases and phosphatases through conserved leucine/isoleucine motifs. Spinophilin targeted PP1 to the N-terminal domain, PR130 directed PP2A to the SPRY 3 domain, PR130 directed PP2A to a region overlapping with SPRY3 domain, and A-kinase anchoring protein targeted PKA to Bsol domain. Homer proteins modulate RyR activity by binding putative proline-containing motifs in the RyR SPRY1 and Jsol domains ([@bib55]; [@bib178]).

Effects of ryanodine and caffeine {#s27}
=================================

Among the large number of drugs that affect SR Ca^2+^ release ([@bib285]; [@bib265]; [@bib233]), ryanodine and caffeine have been extensively used in the assessment of SR-controlling cytoplasmic Ca^2+^ concentrations. Molecular dynamic simulations indicate that ryanodine interacts with residues in the cytosolic cavity of the closed RyR1 ([@bib159]). Single-channel measurements with purified RyRs provide the most direct information on the action of ryanodine. The results show that ryanodine modifies the gating and conductance of RyRs in a characteristic manner ([Fig. 5](#fig5){ref-type="fig"}). After the addition of micromolar ryanodine, a single RyR1 channel entered a subconductance state with a channel P~o~ close to unity. Upon the subsequent addition of millimolar ryanodine, the channel converted to a fully closed state. Because ryanodine binds very slowly to RyRs, ryanodine concentrations in the micromolar to millimolar rather than nanomolar to micromolar range were used. A characteristic property of ryanodine-modified channel states is insensitivity to regulation by Ca^2+^, Mg^2+^, and ATP, all of which greatly affect the gating behavior of unmodified channels. \[^3^H\]Ryanodine binding studies have suggested that binding to a single high-affinity site locks RyRs into an open state, and binding of one or more ryanodine to low-affinity sites closes channels ([@bib116]; [@bib170]; reviewed by [@bib226]).

![**Effect of ryanodine on single purified RyR1.** Single-channel recordings of K^+^ current of purified RyR1 incorporated in a planar lipid bilayer. The top trace shows the appearance of an subconductance state with P~o~ ∼1, several minutes after the addition of 30 µM ryanodine to the cis cytosolic side of the bilayer. The bottom trace illustrates the transition from the subconductance state to a fully closed state within 1 min after the addition of 2 mM ryanodine. Bars on left indicate the open (o) and closed (c) channel. From [@bib116].](JGP_201711878_Fig5){#fig5}

Caffeine binds to a site encompassing the S2-S3 linker and CTD, contacting residues RyR1-Trp4716 and RyR1-Ile4996, respectively ([@bib37]; [Fig. 4 C](#fig4){ref-type="fig"}). In contrast to ryanodine, caffeine (1,3,7-trimethylxanthine) activated purified RyR1 by increasing channel open probability without significantly affecting single-channel conductance ([@bib191]). Another difference is that caffeine activates the Ca^2+^ release channel without loss of sensitivity to regulation by Ca^2+^, Mg^2+^, and ATP. Among 30 xanthines tested, 1,7-dimethylxanthine and 1-hexyl-3,7-dimetylxanthine (pentifylline) were most effective in activating RyR1 in a \[^3^H\]ryanodine binding assay ([@bib128]).

RyRs and muscle disorders {#s28}
=========================

Naturally occurring mutations in RyR1 give rise to a variety of muscle diseases that include MH, CCD, and MmD ([@bib239]) A list of mutations potentially associated with RyR1 is available at <http://www.dmd.nl/nmdb2/variants.php?select_db=RYR1&action=search_all&order>. MH is an inherited disease that causes a rapid rise in body temperature and inappropriate muscle contraction when the affected persons receive general anesthesia and MH-linked RyR1 mutations release Ca^2+^ ions from the SR. MH-linked RyR1 mutations were initially mapped to the N-terminal and central domains of RyR1; however, more recently identified MH mutations are distributed throughout the RyR1 coding sequence ([@bib188]; [@bib218]; [@bib239]). MH is treated with dantrolene, a muscle relaxant that reduces the rate of SR Ca^2+^ release ([@bib285]). Recent studies have shown that two RyR1 ligands, CaM ([@bib163]) and an increase in metabolite Mg^2+^ from MgATP hydrolysis during increased muscle activity ([@bib29]), facilitate dantrolene inhibition. CCD and MmD are congenital diseases associated with a dysfunctional RyR1 ([@bib239]). In many cases, dominant RyR1 mutations linked to CCD localize to the C-terminal domain of the channel. RyR1 with homozygous mutations associated with core myopathies often do not conduct Ca^2+^, whereas heterozygous RyR1 channels composed of wild-type and mutant subunits conduct variable amounts of Ca^2+^ ([@bib267]). More than 150 RyR2 mutations have been potentially linked to cardiac diseases such as CPVT and ARVD2 ([@bib70]; [@bib123]). CPVT is an inherited cardiac disorder characterized by life-threatening arrhythmias elicited by stress and emotional disturbances. ARVD is an inherited RyR2-linked disorder that results in arrhythmias in the right ventricle.

Conclusion {#s29}
==========

Determination of RyR structure at near atomic resolution has opened the way for systematic studies on the molecular properties of a key component of skeletal and cardiac muscle function, as well as in other tissues that express RyRs such as brain and smooth muscle. Understanding the structure--function relationships of RyRs will help to explain the molecular mechanisms associated with myocardial myopathies. The combined results of structural, functional, and computational approaches have contributed basic biochemical, pharmacological, and electrophysiological information on RyR function that has set the stage for future studies of the complex regulatory mechanisms of RyRs by Ca^2+^ and other small molecules, posttranslational modifications, and accessory proteins. However, the recent identification of RyR-binding sites may not sufficiently explain their regulation by Ca^2+^ and ATP, with additional activation sites possible for these ligands. The use of lanthanides may continue to identify Ca^2+^-activating sites and the location of Ca^2+^- and Mg^2+^-inactivating sites. In skeletal muscle E-C coupling, Ca~v~1.1 activation may render a recently identified RyR1 activation site accessible to SR luminal Ca^2+^, resulting in Ca^2+^-induced Ca^2+^ release. Further studies are needed to address the mechanism of SR Ca^2+^ release and determine how SR Ca^2+^ release is terminated in cardiac muscle. Accessory proteins such as CaM and posttranslational modifications may affect RyR structure and activity. Structural information may facilitate genetic correction of disease-associated mutations and the development of new small molecules to inhibit disease progression. Studies on the RyRs will continue to contribute to understanding the structural framework that underlies RyR function.
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